COMMUNIQUÉS West-GlobeNewswire

-
argenx receives feedback from FDA in end-of-phase 2 meeting for efgartigimod in myasthenia gravis
06/06/2018 -
Kraig Biocraft Laboratories provides a statement on the market's response to recent Company milestones and the creation of its Vietnamese subsidiary
06/06/2018 -
Healthcare of Ontario Pension Plan honours Canadian properties and tenants in its portfolio at seventh annual LEAP Awards
06/06/2018 -
Compass Cannabis Clinics Announces Licensed Retail Outlet in Saskatchewan
06/06/2018 -
Great Canadian Healthcare Debate Result: Health Leaders Make Universality of Mental Health their Top Priority
05/06/2018 -
Résultat du Grand débat sur les soins de santé au Canada : les leaders en santé font de l’universalité de la santé mentale leur principale priorité
05/06/2018 -
Chimerix to Address Congressional Subcommittee in Support of Reauthorization of the Pandemic and All-Hazards Preparedness Act (PAHPA)
05/06/2018 -
Teligent, Inc. Announces Closing Of $25 Million Secured Credit Facility
05/06/2018 -
Portola Pharmaceuticals to Present at Two Upcoming Investor Conferences
05/06/2018 -
MannKind Establishes Market Price Stock Purchase Plan
05/06/2018 -
MacroGenics to Present at Jefferies Global Healthcare Conference
05/06/2018 -
Madrigal Pharmaceuticals Announces Proposed Public Offering of Common Stock
05/06/2018 -
GBT Announces New Employment Inducement Grants
05/06/2018 -
Akcea Therapeutics Appoints Industry Leader Dr. Richard Moscicki to Board of Directors
05/06/2018 -
Aptose Biosciences Announces Results of Annual Meeting of Shareholders
05/06/2018 -
VBL Therapeutics Presents Positive Data on its MOSPD2 Platform Technology in Oncology and Inflammation at BIO 2018
05/06/2018 -
Vericel Corporation Announces Closing of $74.8 Million Public Offering and Full Exercise of The Underwriters’ Option to Purchase Additional Shares
05/06/2018 -
Allscripts to present at Baird’s 2018 Global Consumer, Technology & Services Conference
05/06/2018 -
argenx selected for BEL 20 Index
05/06/2018
Pages